Global Health Investment Fund
Impact investorNew York · 1 people tracked
Investment thesis
GHIC catalyzes health innovation by leveraging venture capital investments to strengthen global health security and address urgent public health challenges. The organization prioritizes technologies targeting diseases disproportionately affecting underserved populations, including infectious diseases like HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA and the U.S. Department of Health and Human Services, GHIC supports development and commercialization of technologies that respond to or prevent public health emergencies, pandemics, and global health security threats.
Source: firm website, verified Aug 6, 2026.
Team · 1 people
from public directories
Founder mafia
2 people who came through Global Health Investment Fund went on to found or lead other companies.
Frequently asked questions
- What sectors does Global Health Investment Fund focus on?
- Global Health Investment Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Fund located?
- Global Health Investment Fund is headquartered in New York, US.
Media · Podcasts & interviews
featuring the teamInterview with Curt LaBelle, Global Health Investment Fund
IPEM · Curt LaBelle
Co-investors · 2
Laerdal Million Lives Fund is an investor focused on health technology companies.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity while generating sustainable financial returns.
Firms observed investing alongside Global Health Investment Fund, from public investor directories. Shared companies are the overlap with Global Health Investment Fund's recorded portfolio.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.